首页> 美国卫生研究院文献>Gut and Liver >The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer
【2h】

The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer

机译:常见药物在胰腺癌防治中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Survival from pancreatic cancer remains poor. Conventional treatment has resulted in only marginal improvements in survival compared with survival in the previous several decades. Thus, considerable interest has emerged regarding the potential use of common pharmaceutical agents as chemopreventative and chemotherapeutic options. Aspirin, metformin, statins, β-blockers, and bisphosphonates have biologically plausible mechanisms to inhibit pancreatic neoplasia, whereas dipeptidyl-peptidase 4 inhibitors may promote it. Regardless, real-world epidemiological data remain inconclusive. This review examines the hypotheses, evidence, and current state of the literature for each of these medications and their potential roles in the prevention and treatment of pancreatic cancer.
机译:胰腺癌的存活率仍然很差。与过去几十年的生存相比,常规治疗仅导致生存的微小改善。因此,关于将普通药剂作为化学预防和化学治疗选择的潜在用途已经引起了相当大的兴趣。阿司匹林,二甲双胍,他汀类药物,β受体阻滞剂和双膦酸盐具有生物学上合理的抑制胰腺肿瘤的机制,而二肽基肽酶4抑制剂则可能促进胰腺癌的形成。无论如何,现实世界的流行病学数据仍然没有定论。这篇综述检查了每种药物的假设,证据和文献现状,以及它们在预防和治疗胰腺癌中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号